Hedge funds bleed as AbbVie reconsiders Shire bid
October 15, 2014 at 11:51 AM EDT
LONDON, Oct 15 (Reuters) - Some of the world's best known hedge funds lost hundreds of millions of dollars in the value of the stock they hold as Shire plunged after AbbVie's decision to reconsider its $55 billion bid for the British healthcare group.
